Analysis of Brentuximab Vedotin Plus  CHP (A+CHP) #ASH19 @OfficialUoM

Analysis of Brentuximab Vedotin Plus CHP (A+CHP) #ASH19 @OfficialUoM

ash

6 months
16 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Timothy Illidge, MD, PhD of @OfficialUoM provides analysis of brentuximab vedotin plus CHP (A+CHP) in the frontline treatment of patients with CD30+ peripheral T-Cell lymphomas (ECHELON-2).

Up Next Autoplay